Akero Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AKRO Nasdaq 2836 akerotx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Akero Therapeutics, Inc.

Akero Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - Jun 3rd, 2025 5:00 am
Akero Therapeutics to Present at the Jefferies Global Healthcare Conference - May 28th, 2025 5:00 am
Why Akero Therapeutics, Inc. (AKRO) Skyrocketed Today - May 20th, 2025 9:51 pm
Why Akero Therapeutics (AKRO) Is Among the Best Performing Healthcare Stocks to Buy Now - May 11th, 2025 3:21 pm
Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025 - May 10th, 2025 8:00 am
Akero Therapeutics Reports Positive Trial Data for Prospective Cirrhosis Drug - May 9th, 2025 8:43 am
Akero Therapeutics Presents Week 96 Results from Phase 2b SYMMETRY Clinical Trial of Efruxifermin in Patients with Compensated Cirrhosis Caused by MASH Showing Fibrosis Improvement without Worsening of MASH at the EASL Congress 2025 - May 9th, 2025 5:41 am
Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Trial in the New England Journal of Medicine - May 9th, 2025 5:11 am
Akero Therapeutics to Present at the BofA Securities 2025 Healthcare Conference - May 7th, 2025 2:05 pm
Akero Therapeutics Announces Upcoming Poster and Oral Presentations at the EASL Congress 2025 - Apr 30th, 2025 5:00 am
Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year? - Mar 4th, 2025 7:40 am
Why Akero Therapeutics, Inc. (AKRO) is Skyrocketing So Far in 2025 - Mar 2nd, 2025 7:34 am
Akero Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - Feb 28th, 2025 5:00 am
Is Akero Therapeutics Inc. (AKRO) the Best Performing Mid Cap Stock to Buy According to Analysts? - Feb 27th, 2025 11:23 am
Akero Therapeutics, Inc. (AKRO): the Best Performing Pharma Stock So Far in 2025 - Feb 23rd, 2025 1:18 pm
Akero Therapeutics, Inc. (AKRO): the Best Performing Healthcare Stock So Far in 2025 - Feb 19th, 2025 12:45 pm
Akero Therapeutics Inc. (AKRO): Among The Stocks That Started The Year On A High - Feb 3rd, 2025 10:28 am
This Stock Just Doubled in 1 Day -- Is It Still a Buy? - Feb 2nd, 2025 4:21 pm
Why Akero Therapeutics (AKRO) Is Among the Best Booming Stocks to Invest in Now? - Feb 2nd, 2025 2:35 pm
Akero Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares - Jan 30th, 2025 2:05 pm